Abstract

Since there are no currently accepted therapies for corona virus disease 2019 (COVID-2019), worldwide search for treatment options are ongoing. Convalescent plasma therapy and mesenchymal stem cell therapy are considered as two of potential options. Convalescent plasma therapy may be recommended early during the course of severe or rapidly progressive illness, despite paucity of evidence. However, mesenchymal stem cell therapy for COVID-19 should only be considered in the context of a trial.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.